New Challenging Systemic Therapies for Juvenile Scleroderma: A Comprehensive Review
<b>Background:</b> Juvenile scleroderma (JS) comprises a group of rare chronic autoimmune and fibrosing disorders in children, primarily presenting as juvenile localized scleroderma (jLS) or juvenile systemic sclerosis (jSS). While jLS predominantly affects the skin and subcutaneous tiss...
Saved in:
| Main Authors: | Chiara Sassetti, Claudia Borrelli, Martha Mazuy, Cristina Guerriero, Donato Rigante, Susanna Esposito |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/5/643 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Developing consensus outcome measures in juvenile systemic sclerosis: a global survey of pediatric rheumatologists and literature review
by: Natalia Vasquez-Canizares, et al.
Published: (2025-05-01) -
Clinical and Epidemiological Characteristics of Scleroderma in Children of the Samara Region: a Single-Stage Retrospective Study
by: Juliya S. Bogomolova, et al.
Published: (2025-05-01) -
Scleroderma Renal Crisis as Initial Presentation of Scleroderma
by: Sahil Bagai, et al.
Published: (2022-04-01) -
THE CASE OF THE DEBUT OF SYSTEMIC SCLERODERMA IN A PATIENT AGED 10
by: А. V. BURLUTSKAYA, et al.
Published: (2018-07-01) -
Scleroderma as a paraneoplastic syndrome and tumors associated with scleroderma
by: N. A. Shostak, et al.
Published: (2020-05-01)